{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpolitico-audio-feed.simplecast.com%2Fepisodes%2Fone-vax-patients-rare-journey-HSmASi_O","width":444,"version":"1.0","type":"rich","title":"One vax patient's rare journey","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/c19de819-931e-4d07-823c-6cc5df3ecb2f/193b35b5-e3db-4f9f-9786-4f61106466d2/politico-logo-33.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/f3e6f14e-e4cf-42fe-826f-62f513d2e91b\" height=\"200\" width=\"100%\" title=\"One vax patient&apos;s rare journey\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"An adverse allergic reaction to a covid vaccine is rare, but just how rare remains to be seen. On Wednesday, the National Institutes of Health announced a new study to try to understand the number of people experiencing moderate allergic reaction to mRNA vaccines, and why. Joanne Kenen — who had an allergic reaction to her first Pfizer dose — reports."}